Chris Ehrlich bio- Much experience in these matte
Post# of 72440
(Total Views: 824)
Posted On: 09/30/2019 10:48:34 AM
Chris Ehrlich bio- Much experience in these matters.
Chris Ehrlich
Managing Director
Chris Ehrlich is a Managing Director and Head of Locust Walk’s Biopharmaceutical Practice. He brings a significant biotechnology industry and venture capital experience. Since joining Locust Walk in 2013, Chris has been involved with leading multiple transactions for emerging biopharmaceutical companies including TesoRx in their licensing deal with Aspen Pharma, Thar Pharmaceuticals in the acquisition by Grunenthal and Cymabay in their licensing deal with Kowa Pharmaceuticals. He has also served as an expert witness in several recent biotechnology cases.
Prior to Locust Walk, he was a Managing Director at InterWest Partners. At IW he served on the boards of KAI Pharmaceuticals as the Lead Director (acquired by Amgen), Biomimetic Therapeutics, Inc. (NASD: BMTI, acquired by Wright Medical Technologies) Invuity (NASD: IVTY) and Xenon Pharmaceuticals (NASD: XENE). At all four companies, he sat on the Transaction Committees where he oversaw numerous business development deals.
Prior to joining InterWest, Ehrlich was director, licensing and business development at Purdue Pharma, a private pharmaceutical firm based in Stamford, CT. In this position, he was responsible for developing a biologic oncology franchise, including in-licensing key intellectual properties, establishing and managing collaborations with biotechnology companies and leading the commercial operations of Purdue BioPharma, a biotechnology company located in Princeton, NJ.
Prior to joining Purdue, Ehrlich worked in business development at Genentech, in venture capital at The U.S. Russia Investment Fund, and in biotechnology strategy development at LEK Consulting.
He has an undergraduate degree, cum laude, from Dartmouth College and an MBA from the Kellogg School of Management at Northwestern University.
He currently serves on the Board of Directors of Prostate Management Diagnostics, Inc. and on the Advisory Board of the Peter Michael Foundation, where he is a Senior Advisor. He is as an advisor to Lieutenant Governor Gavin Newsom of California as well as a member of the Young Presidents Organization NorCal Chapter where he serves as Networking Chair.
Chris lives in San Francisco with his wife Sara, and two kids, Charlotte and Harrison.
He is a registered rep with FINRA, holding his Series 79, 63 and 24 licenses.
http://www.locustwalksecurities.com/our-team/chris-ehrlich/
Chris Ehrlich
Managing Director
Chris Ehrlich is a Managing Director and Head of Locust Walk’s Biopharmaceutical Practice. He brings a significant biotechnology industry and venture capital experience. Since joining Locust Walk in 2013, Chris has been involved with leading multiple transactions for emerging biopharmaceutical companies including TesoRx in their licensing deal with Aspen Pharma, Thar Pharmaceuticals in the acquisition by Grunenthal and Cymabay in their licensing deal with Kowa Pharmaceuticals. He has also served as an expert witness in several recent biotechnology cases.
Prior to Locust Walk, he was a Managing Director at InterWest Partners. At IW he served on the boards of KAI Pharmaceuticals as the Lead Director (acquired by Amgen), Biomimetic Therapeutics, Inc. (NASD: BMTI, acquired by Wright Medical Technologies) Invuity (NASD: IVTY) and Xenon Pharmaceuticals (NASD: XENE). At all four companies, he sat on the Transaction Committees where he oversaw numerous business development deals.
Prior to joining InterWest, Ehrlich was director, licensing and business development at Purdue Pharma, a private pharmaceutical firm based in Stamford, CT. In this position, he was responsible for developing a biologic oncology franchise, including in-licensing key intellectual properties, establishing and managing collaborations with biotechnology companies and leading the commercial operations of Purdue BioPharma, a biotechnology company located in Princeton, NJ.
Prior to joining Purdue, Ehrlich worked in business development at Genentech, in venture capital at The U.S. Russia Investment Fund, and in biotechnology strategy development at LEK Consulting.
He has an undergraduate degree, cum laude, from Dartmouth College and an MBA from the Kellogg School of Management at Northwestern University.
He currently serves on the Board of Directors of Prostate Management Diagnostics, Inc. and on the Advisory Board of the Peter Michael Foundation, where he is a Senior Advisor. He is as an advisor to Lieutenant Governor Gavin Newsom of California as well as a member of the Young Presidents Organization NorCal Chapter where he serves as Networking Chair.
Chris lives in San Francisco with his wife Sara, and two kids, Charlotte and Harrison.
He is a registered rep with FINRA, holding his Series 79, 63 and 24 licenses.
http://www.locustwalksecurities.com/our-team/chris-ehrlich/
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼